Patent · US Active

Stabilizing camptothecin pharmaceutical compositions

US12059497B2 · kind B2 · utility

1Cited by

109References

51Claims

0Family size

Assignee

IPSEN BIOPHARM LIMITED · GB

Inventors

Daryl C. Drummond · Lincoln, US
Dmitri B. Kirpotin · San Francisco, US
Mark E. Hayes · Mill Valley, US
Charles O. Noble · San Francisco, US
Kevin Kesper · Watertown, US
Antoine M. Awad · Dedham, US
Douglas J. Moore · Newton, US
Andrew J. O'Brien · Franklin, US

Key dates

Filing date	Mar 22, 2021
Grant date	Aug 13, 2024
Priority date	—
Expiry date	Oct 17, 2041

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10S977/907
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Irinotecan phospholipid liposomes with improved storage stability are provided, with related methods of treatment and manufacture. The irinotecan liposomes can have reduced formation of lyso-phosphatidylcholine (lyso-PC) during storage, and prior to administration to a patient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.